跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEMETREXED ADVAGEN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG/ VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
PEMETREXED ADVAGEN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG/ VIAL
Approved
STANDARD
PEMETREXED ADVAGEN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG/ VIAL
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
105dee87f00edbe1
Company
Unknown
Type
Standard
Approval Details
Approval Id
105dee87f00edbe1
Drug Name
PEMETREXED ADVAGEN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG/ VIAL
Active Ingredients
Pemetrexed Disodium hemipentahydrate eqv. Pemetrexed
500.00 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
105dee87f00edbe1
Type
Standard
Back to HSA Approvals
